Bookmark and Share

William A. Blattner

William A. Blattner M.D.

Academic Title: Professor
Primary Appointment: Medicine
Secondary Appointments: Epidemiology & Public Health
Additional Title(s): Associate Director, Institute of Human Virology and Director, Division of Epidemiology and Prevention, Institute of Human Virology
Location: Institute of Human Virology, Room N449
Phone: (410) 706-1941
Fax: (410) 706-1944

Personal History:

As Professor of Medicine and Chief, Division of Cancer Epidemiology at the University of Maryland, Baltimore, Dr. Blattner is an internationally renowned authority on the viral epidemiology of cancer. Before coming to the University of Maryland, Dr. Blattner graduated from Washington University School of Medicine, interned at Strong Memorial Hospital, completed residencies at the New York Cornell Medical Center and Memorial Sloan Kettering Cancer Institute, and did his medical oncology training at the National Cancer Institute in Bethesda. At the NCI, he occupied increasingly complex leadership positions, first as a Section Head of the Division of Cancer Epidemiology and Genetics, and subsequently as Viral Epidemiology Branch Chief. While at the NCI, among other projects, Dr. Blattner researched the etiology of HTLV-1 in adult T-cell leukemia and the role of the p53 mutation in Li Fraumeni Syndrome, in addition to pioneering studies of HIV cancer linkage.


  1. Anude, C.J., Eze, E., Onyegbutulem, H.C., Charurat, M., Etiebet, M.A., Ajayi, S., Dakum, P., Akinwande, O., Beyrer, C., Abimiku, A.L., Blattner, W. Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria. BMC Infect Dis. 2013 Mar 1;13(1):113.
  2. Omoni, A.O., Christian, P.S., Sadoh, W.E., Okechukwu, A., Olateju, E., Omoigberale, A., Blattner, W., Charurat, M.E. Immunologic Outcomes of Antiretroviral Therapy among HIV-Infected Nigerian Children and its Association with Early Infant Feeding and Nutritional Status at Treatment Initiation. Pediatr Infect Dis J. 2013 Feb 13. [Epub ahead of print]
  3. Etiebet MA, Shepherd J, Nowak RG, Charurat M, Chang H, Ajayi S, Elegba O, Ndembi N, Abimiku A, Carr JK, Eyzaguirre LM, Blattner W.A., Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy. AIDS. 2013 Feb 20;27(4):553-61.
  4. Jedy-Agba, E.E., Curado, M.P., Oga, E., Samaila, M.O., Ezeome, E.R., Obiorah, C., Erinomo, O.O., Ekanem, I.O., Uka, C., Mayun, A., Afolayan, E.A., Abiodun, P., Olasode, B.J., Omonisi, A., Out, T., Osinubi, P., Dakum, P., Blattner, W., Adebamowo, C.A. The role of hospital-based cancer registries in low and middle income countries-The Nigerian Case Study. Cancer Epidemiol. 2012 Oct;36(5):430-5. Epub 2012 Jun 15.
  5. Jedy-Agba, E., Curado, M.P., Ogunbiyi, O., Oga, E., Fabowale, T., Igbinoba, F., Osubor, G., Out, T., Kumai, H., Koechlin, A., Osinubi, P., Dakum, P., Blattner, W., Adebamowo, C.A. Cancer incidence in Nigeria: A report from population-based cancer registries. Cancer Epidemio. 2012 Oct;36(5):e271-8. Epub 2012 May 22.
  6. Royal, W. 3rd, Cherner, M., Carr, J., Habib, A.G., Akomolafe, A., Abimiku, A., Charurat, M., Farley, J., Oluyemisi, A., Mamadu, I., Johnson, J., Ellis, R., McCutchen, J.A., Grant, I., Blattner, W.A. Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria. J Neurovirol. 2012 Jun;18(3):191–9. Epub 2012 Apr 18.
  7. Collins-Fairclough, A.M., Charurat, M., Nadai, Y., Pando, M.A., Avila, M.M., Blattner, W.A., Carr, J.K. Significantly Longer EnvelopeV2 Loops are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad. PLoS ONE. 2011;6(6):e19995. Epub 2011 Jun 17. PMCID: PMC3117786.
  8. Maloney, E.M., Wiktor, S.Z., Palmer, P., Cranston, B., Pate, E.J., Cohn, S., Kim, N., Miley, W., Thomas, T.L., Blattner, W.A., Hanchard, B. A cohort study of health effects of human T-cell lymphotropic virus type I infection in Jamaican children. Pediatrics. 2003Aug;112(2):e136–42. PMID: 12897319.
  9. Goedert, J.J., Charurat, M., Blattner, W.A., Hershow, R.C., Pitt, J., Diaz, C., Mofenson, L.M., Green, K., Minkoff, H., Paul, M.E., Thomas, D.L., Whitby, D. and the Women and Infants Transmission Study. Risk factors for Kaposi’s sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA. AIDS. 2003 Feb 14;17(3):425–33. PMID: 12556697.
  10. Blattner, W.A. Human retroviruses: their role in cancer. Proc Assoc Am Physicians. 1999 Nov–Dec;111(6):563–72. Review. PMID: 10591085.
  11. Manns, A., Hanchard, B., Morgan, O., Wilks, R., Cranston, B., Nam, J., Blank, M., Kuwayama, M., Yashiki, S., Fujiyoshi, T., Blattner, W.A., Sonoda, S. Human leukocyte antigen Class II alleles associated with HTLV-I infection and adult T-cell leukemia/lymphoma in a black population. J Natl Cancer Inst. 1998 Apr 15;90(8):617–22. PMID: 9554445.
  12. Cote, T.R., Biggar, R.J., Rosenberg, P.S., Devesa, S.S., Percy, C., Yellin, F.J., Lemp, G., Hardy, C., Geodert, J.J., and Blattner, W.A. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/ Cancer Study Group. Int J Cancer. 1997 Nov 27;73(5):645–50. PMID: 9398040.
  13. Rattray, C., Strickler, H.D., Escoffery, C., Cranston, B., Brown, C., Manns, A., Schiffman, M.H., Palefsky, J.M., Hanchard, B., and Blattner, W.A. Type-specific prevalence of human papillomavirus DNA among Jamaican colposcopy patients. J Infect Dis. 1996 Mar;173(3):718–21. PMID: 8627038.
  14. Strickler, H.D., Rattray, C., Escoffery, C., Manns, A., Schiffman, M.H., Palefsky, J.M., Hanchard, B. and Blattner, W.A. Human T-cell lymphotropic virus type I and severe cervical neoplasia in Jamaica. Int J Cancer. 1995 Mar 29;61(1):23–6. PMID: 7705929.
  15. Cleghorn, F.R., Manns, A., Falk, R., Hartge, P., Hanchard, B., Jack, N., Williams, E., Jaffe, E., White, F., Bartholomew, C., and Blattner, W.A. Effect of Human T-Lymphotropic Virus Type I infection on Non-Hodgkin’s Lymphoma incidence. J Nat Cancer Inst. 1995 Jul 5;87(13):1009–14. PMID: 7629870.